CompletedNot Applicable

Propofol Anesthesia and Perinatal Outcome

Turkey (Türkiye)102 participantsStarted 2023-08-01

Plain-language summary

The effects of intravenous propofol administration for general anesthesia in cesarean deliveries on maternal and infant health will be evaluated in relation to maternal and umbilical cord blood propofol levels.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being pregnant in ASA category 1-2 * \>39 weeks of healthy pregnancy * \>28 weeks complicated pregnancy * Cesarean delivery with or without action * Providing induction of general anesthesia with intravenous propofol Exclusion Criteria: * Pregnant women under the age of 18, * Those who have stillbirth, * Severe chronic kidney and liver disease, * Neurological disease * Those with other systemic diseases

What they're measuring

Blood propofol concentration

Timeframe: The first 5 minutes of cesarean delivery

Trial details

NCT IDNCT07035899

SponsorHaseki Training and Research Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-01

View on ClinicalTrials.gov More Pregnancy Complications trials